Safer Prescribing Webinar Series
Upcoming Sessions
We are currently planning our 2027 Safer Prescribing Series!
The best way to learn about our upcoming events and webinars is to subscribe to our newsletter.
Past Session Recordings
Reviewing the CDC Clinical Practice Guidelines
MOUD and Acute Pain Management
Effective Conversations about Pain Management
MOUD and Pregnancy
Continuing Education Credits
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Injury Prevention Center. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation:
MyMichigan Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MyMichigan Health designates this live activity for a maximum of 1.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Event Disclosures:
Speakers:
Alek Adkins, MD, Michael Smith, PharmD, and Amy Vandenberg, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Alek Adkins, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Potentially gabapentin for alcohol use disorder Buprenorphine & benzodiazepine co-administration
Michael Smith, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Acetaminophen and non-steroidal anti-inflammatory drug off-label use for dental-related pain.
Amy Vandenberg, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: alternative treatments for anxiety (eg, prazosin, propranolol)
Elizabeth Haberkorn, DNP, Deborah Russell, APRN, and Michael Smith, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Planners and other Administrative Support:
Lisa Orrison, Taylor Hautala, Nichole Burnside, and Jill Solomon have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.”
